Stamm
Next-generation biomanufacturing platform using microfluidics and 3D printing
Stamm is revolutionizing the field of biomanufacturing with its next-generation platform that integrates microfluidics and 3D printing technologies. Our mission is to transform healthcare by enabling the rapid and cost-effective production of complex biological materials. By leveraging cutting-edge microfluidic systems, Stamm enhances precision and scalability in the manufacturing process, paving the way for innovative therapies and personalized medicine. Our platform aims to address critical challenges in the biotech industry, fostering advancements in human-machine interfaces and improving patient outcomes. Through continuous innovation, Stamm is committed to driving the future of healthcare and biotechnology.
Testimonial
Related Companies
Klona Biotech
The future of human tissue replacements using 3D printing
London, United Kingdom
Lyric Bio
Pioneering the future of biomanufacturing using proven and proprietary 3D bioprinting and tissue engineering technologies
San Carlos, California
Eywa Biotech
Scaling the production of pharmaceutical-grade psychedelic compounds through synthetic biology
Montevideo, Uruguay · Buenos Aires, Argentina
PrettyLitter
Develops a lightweight cat litter that helps cat owners monitor their pets' health by changing colors in response to abnormalities in urine.
Los Angeles, United States
nVision
nVision’s focus is on women’s health. The company created the first FDA-cleared device for collecting cells from the fallopian tubes, which aimed to enable earlier diagnosis of ovarian cancer. In 2018, nVision was acquired by Boston Scientific.
Senodia
MEMS sensors for various applications.
China, Shanghai
Aanika
Innovative science-backed insurance solutions for agriculture and food industries with Bio technology.
Brooklyn, United States
